Researchers from University of Barcelona Provide Details of New Studies and Findings in the Area of Liver Cancer (Easl Position Paper On Clinical Follow-up After Hcv Cure).

A recent report from researchers at the University of Barcelona provides guidance on the clinical follow-up of patients who have been cured of hepatitis C virus (HCV) infection. The report addresses questions regarding the management of patients after treatment with direct-acting antivirals (DAAs), which can cure HCV in most cases. The recommendations cover follow-up for patients without advanced fibrosis, those with compensated advanced chronic liver disease, and those with decompensated cirrhosis. The report also includes guidance on assessing the risk of hepatocellular carcinoma and managing extrahepatic manifestations of HCV. The recommendations are based on the best available evidence and aim to assist healthcare professionals in the post-treatment management of HCV patients. [Extracted from the article]